Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE

American Journal of Pathology

Volumn 182, Issue 6, 2013, Pages 2322-2331

  Zou, Kun ^a   Liu, Junjun ^a   Watanabe, Atsushi ^b   Hiraga, Saeko ^a   Liu, Shuyu ^a   Tanabe, Chiaki ^a   Maeda, Tomoji ^a   Terayama, Yasuo ^a   Takahashi, Satoshi ^a   Michikawa, Makoto ^b   Komano, Hiroto ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[1-43]; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE; MUTANT PROTEIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DOMAIN; SPECIES;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CAPTOPRIL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PRESENILINS;

EID: 84878244551     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.053     Document Type: Article

References (26)

1. D.J. Selkoe Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases Nat Cell Biol 6 2004 1054 1061
2. J. Kim, L. Onstead, S. Randle, R. Price, L. Smithson, C. Zwizinski, D.W. Dickson, T. Golde, and E. McGowan Abeta40 inhibits amyloid deposition in vivo J Neurosci 27 2007 627 633
3. D.J. Selkoe Resolving controversies on the path to Alzheimer's therapeutics [Erratum appeared in Nat Med 2011, 17:1521 and in Nat Med 2011, 17:1693] Nat Med 17 2011 1060 1065
4. D.J. Selkoe, and M.S. Wolfe Presenilin: running with scissors in the membrane Cell 131 2007 215 221
5. H. Welander, J. Frånberg, C. Graff, E. Sundström, B. Winblad, and L.O. Tjernberg Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains J Neurochem 110 2009 697 706
6. A. Hirayama, Y. Horikoshi, M. Maeda, M. Ito, and S. Takashima Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome Brain Dev 25 2003 180 185
7. T. Saito, T. Suemoto, N. Brouwers, K. Sleegers, S. Funamoto, N. Mihira, Y. Matsuba, K. Yamada, P. Nilsson, J. Takano, M. Nishimura, N. Iwata, C. Van Broeckhoven, Y. Ihara, and T.C. Saido Potent amyloidogenicity and pathogenicity of Abeta43 Nat Neurosci 14 2011 1023 1032
8. K. Zou, H. Yamaguchi, H. Akatsu, T. Sakamoto, M. Ko, K. Mizoguchi, J.S. Gong, W. Yu, T. Yamamoto, K. Kosaka, K. Yanagisawa, and M. Michikawa Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition J Neurosci 27 2007 8628 8635
9. J.S. Elkins, V.C. Douglas, and S.C. Johnston Alzheimer disease risk and genetic variation in ACE: a meta-analysis Neurology 62 2004 363 368
10. D.J. Lehmann, M. Cortina-Borja, D.R. Warden, A.D. Smith, K. Sleegers, J.A. Prince, C.M. van Duijn, and P.G. Kehoe Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease Am J Epidemiol 162 2005 305 317
11. K. Zou, T. Maeda, A. Watanabe, J. Liu, S. Liu, R. Oba, Y. Satoh, H. Komano, and M. Michikawa Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme J Biol Chem 284 2009 31914 31920
12. L. Keller, H. Welander, H.H. Chiang, L.O. Tjernberg, I. Nennesmo, A.K. Wallin, and C. Graff The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Abeta in different brain regions Eur J Hum Genet 18 2010 1202 1208
13. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J Neurosci 20 2000 4050 4058
14. E. Masliah, R.D. Terry, M. Mallory, M. Alford, and L.A. Hansen Diffuse plaques do not accentuate synapse loss in Alzheimer's disease Am J Pathol 137 1990 1293 1297
15. T. Wyss-Coray, C. Lin, F. Yan, G.Q. Yu, M. Rohde, L. McConlogue, E. Masliah, and L. Mucke TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice Nat Med 7 2001 612 618
16. E. McGowan, F. Pickford, J. Kim, L. Onstead, J. Eriksen, C. Yu, L. Skipper, M.P. Murphy, J. Beard, P. Das, K. Jansen, M. Delucia, W.L. Lin, G. Dolios, R. Wang, C.B. Eckman, D.W. Dickson, M. Hutton, J. Hardy, and T. Golde Abeta42 is essential for parenchymal and vascular amyloid deposition in mice Neuron 47 2005 191 199
17. K. Yaffe, A. Weston, N.R. Graff-Radford, S. Satterfield, E.M. Simonsick, S.G. Younkin, L.H. Younkin, L. Kuller, H.N. Ayonayon, J. Ding, and T.B. Harris Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline JAMA 305 2011 261 266
18. K. Blennow, and H. Hampel CSF markers for incipient Alzheimer's disease Lancet Neurol 2 2003 605 613
19. H. Akatsu, N. Ogawa, T. Kanesaka, A. Hori, T. Yamamoto, N. Matsukawa, and M. Michikawa Higher activity of peripheral blood angiotensin-converting enzyme is associated with later-onset of Alzheimer's disease J Neurol Sci 300 2011 67 73
20. K. Yanagisawa, A. Odaka, N. Suzuki, and Y. Ihara GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease Nat Med 1 1995 1062 1066
21. R.W. Shin, K. Ogino, A. Kondo, T.C. Saido, J.Q. Trojanowski, T. Kitamoto, and J. Tateishi Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain J Neurosci 17 1997 8187 8193
22. K. Zou, D. Kim, A. Kakio, K. Byun, J.S. Gong, J. Kim, M. Kim, N. Sawamura, S. Nishimoto, K. Matsuzaki, B. Lee, K. Yanagisawa, and M. Michikawa Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain J Neurochem 87 2003 609 619
23. M.S. Wolfe When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking point on the role of presenilin mutations in Alzheimer disease EMBO Rep 8 2007 136 140
24. P.A. Deddish, J. Wang, B. Michel, P.W. Morris, N.O. Davidson, R.A. Skidgel, and E.G. Erdos Naturally occurring active N-domain of human angiotensin I-converting enzyme Proc Natl Acad Sci USA 91 1994 7807 7811
25. N.M. Hooper, and A.J. Turner An ACE structure Nat Struct Biol 10 2003 155 157
26. I. Kuperstein, K. Broersen, I. Benilova, J. Rozenski, W. Jonckheere, M. Debulpaep, A. Vandersteen, I. Segers-Nolten, K. Van Der Werf, V. Subramaniam, D. Braeken, G. Callewaert, C. Bartic, R. D'Hooge, I.C. Martins, F. Rousseau, J. Schymkowitz, and B. De Strooper Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio EMBO J 29 2010 3408 3420